382 related articles for article (PubMed ID: 6833756)
1. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: low responsiveness to interferon inducers.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1983 Apr; 130(4):1980-4. PubMed ID: 6833756
[TBL] [Abstract][Full Text] [Related]
2. Genetic control of the natural killer cell activity in SJL and other strains of mice.
Kaminsky SG; Nakamura I; Cudkowicz G
J Immunol; 1985 Jul; 135(1):665-71. PubMed ID: 3923115
[TBL] [Abstract][Full Text] [Related]
3. Defective differentiation of natural killer cells in SJL mice. Role of the thymus.
Kaminsky SG; Milisauskas V; Chen PB; Nakamura I
J Immunol; 1987 Feb; 138(4):1020-5. PubMed ID: 3543120
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
Holmes KV; Welsh RM; Haspel MV
J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
[TBL] [Abstract][Full Text] [Related]
5. 5-halo-6-phenyl pyrimidinones: new molecules with cancer therapeutic potential and interferon-inducing capacity are strong inducers of murine natural killer cells.
Lotzová E; Savary CA; Stringfellow DA
J Immunol; 1983 Feb; 130(2):965-9. PubMed ID: 6848603
[TBL] [Abstract][Full Text] [Related]
6. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
[TBL] [Abstract][Full Text] [Related]
7. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of mouse natural killer cell activity by LS 2616, a new immunomodulator.
Kalland T; Alm G; Stålhandshe T
J Immunol; 1985 Jun; 134(6):3956-61. PubMed ID: 2580900
[TBL] [Abstract][Full Text] [Related]
10. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
[TBL] [Abstract][Full Text] [Related]
11. Augmentation of mouse natural killer cell activity by interferon and interferon inducers.
Djeu JY; Heinbaugh JA; Holden HT; Herberman RB
J Immunol; 1979 Jan; 122(1):175-81. PubMed ID: 310826
[TBL] [Abstract][Full Text] [Related]
12. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
13. Genetics, regulation, and specificity of murine natural antitumor antibodies and natural killer cells.
Chow DA; Wolosin LB; Greenberg AH
J Natl Cancer Inst; 1981 Aug; 67(2):445-53. PubMed ID: 6943381
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
Sharma BS; Mhaskar S; Balazs L; Siaw M
Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
[TBL] [Abstract][Full Text] [Related]
15. Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).
Dorshkind K; Pollack SB; Bosma MJ; Phillips RA
J Immunol; 1985 Jun; 134(6):3798-801. PubMed ID: 3989296
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
Hanna N; Schneider M
J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
[TBL] [Abstract][Full Text] [Related]
17. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes.
Itoh H; Abo T; Sugawara S; Kanno A; Kumagai K
J Immunol; 1988 Jul; 141(1):315-23. PubMed ID: 3379309
[TBL] [Abstract][Full Text] [Related]
18. The chemiluminescence response of human natural killer cells. II. Association of a decreased response with low natural killer activity.
Werkmeister J; Helfand S; Roder J; Pross H
Eur J Immunol; 1983 Jun; 13(6):514-20. PubMed ID: 6574914
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
Stein-Streilein J; Bennett M; Mann D; Kumar V
J Immunol; 1983 Dec; 131(6):2699-704. PubMed ID: 6644021
[TBL] [Abstract][Full Text] [Related]
20. Natural killer activity of gut mucosal lymphoid cells in mice.
Tagliabue A; Luini W; Soldateschi D; Boraschi D
Eur J Immunol; 1981 Nov; 11(11):919-22. PubMed ID: 7327195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
